11th Mar 2019 14:03
LONDON (Alliance News) - Drug development services firm Ergomed PLC on Monday said Non-Executive Director Chris Collins died on Friday last week.
Collins had been on the company's board since its initial public offering in July 2014.
"Chris played a key role in bringing Ergomed to the public market and has been a source of invaluable advice to the board, based on his long career in the City," Chair Miroslav Reljanovic said.
He added: "On behalf of everybody at Ergomed, I extend our sincerest condolences to Chris's family at this very sad and tragic loss."
Ergomed shares were untraded on Monday afternoon, last quoted at 166 pence each.
Related Shares:
ERGO.L